Laporan Laba Rugi (TTM)
Laporan Laba Rugi Maternus-Kliniken Aktiengesellschaft menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 116 | 114 | 115 | 116 | 114 | 111 | 111 | 110 | 108 | 107 | 105 | 102 | 102 | 106 | 109 | 111 | 114 |
| Change (%) | -1.26 | 0.58 | 0.57 | -1.81 | -1.84 | -0.72 | -0.72 | -1.43 | -1.45 | -1.98 | -2.02 | -0.17 | 3.13 | 3.03 | 2.44 | 2.38 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 89 | 87 | 86 | 86 | 84 | 83 | 84 | 85 | 88 | 90 | 91 | 91 | 94 | 90 | 90 | 93 | 92 |
| Change (%) | -3.00 | -0.55 | -0.56 | -1.84 | -1.88 | 1.42 | 1.40 | 3.09 | 3.00 | 0.27 | 0.27 | 4.01 | -4.25 | -0.03 | 2.94 | -1.44 | |
| % of Revenue | 77.28 | 75.93 | 75.07 | 74.23 | 74.20 | 74.17 | 75.77 | 77.39 | 80.94 | 84.60 | 86.54 | 88.56 | 92.27 | 85.66 | 83.12 | 83.52 | 80.41 |
| Gross Operating Profit | 26 | 28 | 29 | 30 | 29 | 29 | 27 | 25 | 21 | 16 | 14 | 12 | 8 | 15 | 18 | 18 | 22 |
| Change (%) | 4.64 | 4.14 | 3.98 | -1.70 | -1.73 | -6.86 | -7.36 | -16.92 | -20.36 | -14.32 | -16.71 | -32.52 | 91.18 | 21.32 | -0.03 | 21.71 | |
| % of Revenue | 22.72 | 24.07 | 24.93 | 25.77 | 25.80 | 25.83 | 24.23 | 22.61 | 19.06 | 15.40 | 13.46 | 11.44 | 7.73 | 14.34 | 16.88 | 16.48 | 19.59 |
| SG&A | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Change (%) | -68.76 | 1.86 | 1.83 | -15.67 | -18.58 | -4.18 | -4.36 | -3.42 | -3.54 | -23.88 | -31.37 | 0.00 | |||||
| % of Revenue | 1.11 | 0.35 | 0.36 | 0.36 | 0.31 | 0.26 | 0.25 | 0.24 | 0.23 | 0.23 | 0.18 | 0.12 | 0.17 | 0.16 | |||
| R&D | |||||||||||||||||
| Change (%) | |||||||||||||||||
| % of Revenue | |||||||||||||||||
| OpEx | 118 | 114 | 114 | 114 | 111 | 110 | 111 | 112 | 114 | 117 | 117 | 116 | 112 | 111 | 110 | 114 | 118 |
| Change (%) | -3.27 | -0.12 | -0.12 | -2.09 | -0.96 | 0.75 | 0.74 | 2.17 | 2.13 | -0.22 | -0.22 | -4.09 | -0.61 | -0.61 | 3.53 | 3.41 | |
| % of Revenue | 101.84 | 99.77 | 99.09 | 98.41 | 98.13 | 99.00 | 100.46 | 101.94 | 105.67 | 109.51 | 111.47 | 113.51 | 109.05 | 105.10 | 101.38 | 102.47 | 103.50 |
| Operating Income | -2 | 0 | 1 | 2 | 2 | 1 | -1 | -2 | -6 | -10 | -12 | -14 | -9 | -5 | -2 | -3 | -4 |
| Change (%) | -112.16 | 305.79 | 75.36 | 15.44 | -47.73 | -145.91 | 317.83 | 187.79 | 65.25 | 18.25 | 15.43 | -33.13 | -41.90 | -72.10 | 82.88 | 45.32 | |
| % of Revenue | -1.84 | 0.23 | 0.91 | 1.59 | 1.87 | 1.00 | -0.46 | -1.94 | -5.67 | -9.51 | -11.47 | -13.51 | -9.05 | -5.10 | -1.38 | -2.47 | -3.50 |
| Interest Expense | -8 | -7 | -7 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -7 | -8 | -8 | -8 | -8 | -8 |
| Change (%) | -4.95 | -5.82 | -6.18 | -3.00 | -3.10 | -2.25 | -2.31 | 0.32 | 0.32 | 8.72 | 8.02 | 11.35 | 3.65 | 3.52 | 2.00 | 1.96 | |
| % of Revenue | -6.58 | -6.33 | -5.93 | -5.53 | -5.46 | -5.39 | -5.31 | -5.22 | -5.32 | -5.41 | -6.00 | -6.62 | -7.38 | -7.42 | -7.45 | -7.42 | -7.39 |
| Net Income | -10 | -10 | -8 | -7 | -5 | -3 | -4 | -6 | -10 | -14 | -16 | -19 | -14 | -11 | -7 | -10 | -13 |
| Change (%) | -2.78 | -12.57 | -14.38 | -32.75 | -47.14 | 59.08 | 37.14 | 75.98 | 43.18 | 16.65 | 14.27 | -24.02 | -25.86 | -34.88 | 45.56 | 31.30 | |
| % of Revenue | -8.55 | -8.42 | -7.32 | -6.23 | -4.27 | -2.30 | -3.68 | -5.09 | -9.08 | -13.19 | -15.70 | -18.31 | -13.94 | -10.02 | -6.33 | -9.00 | -11.54 |
Source: Capital IQ
